Resveratrol potentiates vitamin D and nuclear receptor signaling

Journal of Cellular Biochemistry

Volumn 116, Issue 6, 2015, Pages 1130-1143

  Dampf Stone, Angelika ^a   Batie, Shane F ^a,b   Sabir, Marya S ^a   Jacobs, Elizabeth T ^c,d   Lee, Jamie H ^a   Whitfield, G Kerr ^b   Haussler, Mark R ^b   Jurutka, Peter W ^a,b  

^a ARIZONA STATE UNIVERSITY WEST   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

ACETYLATION; NUTRACEUTICAL; SIRT1; TRANSACTIVATION; VITAMIN D RECEPTOR

Indexed keywords

CELL NUCLEUS RECEPTOR; RESVERATROL; RETINOID X RECEPTOR; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CELL RECEPTOR; PROTEIN BINDING; STILBENE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIMERIZATION; HOMODIMERIZATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION; VITAMIN D RESPONSIVE ELEMENT; ANIMAL; CACO 2 CELL LINE; CELL LINE; DRUG EFFECTS; GENETICS; HCT116 CELL LINE; METABOLISM; PHYSIOLOGY;

MAMMALIA;

ANIMALS; CACO-2 CELLS; CELL LINE; HCT116 CELLS; HUMANS; MICE; PROTEIN BINDING; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; STILBENES; VITAMIN D RESPONSE ELEMENT;

EID: 84926662817     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25070     Document Type: Article

References (54)

1. Bartik L, Whitfield GK, Kaczmarska M, Lowmiller CL, Moffet EW, Furmick JK, Hernandez Z, Haussler CA, Haussler MR, Jurutka PW,. 2010. Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 21: 1153-1161.
2. Batie S, Lee JH, Haussler MR, Jurutka PW,. 2011. Nutritional crosstalk between resveratrol and vitamin D signaling is mediated by the vitamin D receptor. Proc Ariz-Nev Acad Sci 46: 32.
3. Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE,. 2013. Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists. Bioorg Med Chem 21: 693-702.
4. Baur JA,. 2010. Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804: 1626-1634.
5. Chakraborty S, Levenson AS, Biswas PK,. 2013. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha. BMC Struct Biol 13: 27.
6. Denu JM,. 2012. Fortifying the link between SIRT1, resveratrol, and mitochondrial function. Cell Metab 15: 566-567.
7. Garland CF, Garland FC, Gorham ED,. 1999. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 889: 107-119.
8. Gehm BD, McAndrews JM, Chien PY, Jameson JL,. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143.
9. Gerber-Huber S, Nardelli D, Haefliger JA, Cooper DN, Givel F, Germond JE, Engel J, Green NM, Wahli W,. 1987. Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene. Nucleic Acids Res 15: 4737-4760.
10. Guo C, Sinnott B, Niu B, Lowry MB, Fantacone ML, Gombart AF,. 2014. Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. Mol Nutr Food Res 58: 528-536.
11. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW,. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349.
12. Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, Bartik L, Egan JB, Wu Y, Kubicek JL, Lowmiller CL, Moffet EW, Forster RE, Jurutka PW,. 2010. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol 121: 88-97.
13. Haussler MR, Jurutka PW, Mizwicki M, Norman AW,. 2011a. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH) vitamin D: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 25: 543-559.
14. Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C, Jurutka PW,. 2011. Nuclear vitamin D receptor: Natural ligands, molecular structure-function, and transcriptional control of vital genes. In:, Feldman D, Pike JW, Adams J, editors. Vitamin D. San Diego: Academic Press. pp 137-170.
15. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW,. 2013. Molecular mechanisms of vitamin D action. Calcif Tissue Int 92: 77-98.
16. Hayes DP,. 2011. Resveratrol and vitamin D: Significant potential interpretative problems arising from their mutual processes, interactions and effects. Med Hypotheses 77: 765-772.
17. Hibler EA, Jacobs ET, Stone AD, Sardo CL, Galligan MA, Jurutka PW,. 2014a. Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) 7: 426-434.
18. Hibler EA, Molmenti CL, Lance P, Jurutka PW, Jacobs ET,. 2014b. Associations between circulating 1,25(OH)(2)D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control 25: 809-817.
19. Hofseth LJ, Singh UP, Singh NP, Nagarkatti M, Nagarkatti PS,. 2010. Taming the beast within: Resveratrol suppresses colitis and prevents colon cancer. Aging (Albany NY) 2: 183-184.
20. Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, Burk O,. 2001. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos 29: 1454-1459.
21. Jacobs ET, Martinez ME, Jurutka PW,. 2011. Vitamin D: Marker or mechanism of action. Cancer Epidemiol Biomarkers Prev 20: 585-590.
22. Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, Jurutka PW,. 2013. CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73: 2563-2573.
23. Jantzen HM, Strahle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R, Schutz G,. 1987. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49: 29-38.
24. Juan ME, Alfaras I, Planas JM,. 2012. Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol Res 65: 584-591.
25. Jurutka PW, Thompson PD, Whitfield GK, Eichhorst KR, Hall N, Dominguez CE, Hsieh JC, Haussler CA, Haussler MR,. 2005. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem 94: 917-943.
26. Jurutka PW, Whitfield GK, Forster R, Batie S, Lee J, MRH,. 2013. Vitamin D: A Fountain of Youth in Gene Regulation. In:, Gombart AF, editor. Vitamin D: oxidative stress, immunity, and aging. Boca Raton: CRC Press. pp 3-35.
27. Kim MY, Woo EM, Chong YT, Homenko DR, Kraus WL,. 2006. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol Endocrinol 20: 1479-1493.
28. Kristjansson K, Rut AR, Hewison M, O'Riordan JLH, Hughes MR,. 1993. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25-dihydroxyvitamin D3. J Clin Invest 92: 12-16.
29. Kumazaki M, Noguchi S, Yasui Y, Iwasaki J, Shinohara H, Yamada N, Akao Y,. 2013. Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells. J Nutr Biochem 24: 1849-1858.
30. Li H, Xia N, Forstermann U,. 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26: 102-110.
31. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ,. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science 296: 1313-1316.
32. Marchal J, Pifferi F, Aujard F,. 2013. Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span. Ann NY Acad Sci 1290: 67-73.
33. Masuno H, Ikura T, Morizono D, Orita I, Yamada S, Shimizu M, Ito N,. 2013. Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives. J Lipid Res 54: 2206-2213.
34. Matsubara T, Yoshinari K, Aoyama K, Sugawara M, Sekiya Y, Nagata K, Yamazoe Y,. 2008. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos 36: 2058-2063.
35. Menzies KJ, Singh K, Saleem A, Hood DA,. 2013. Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem 288: 6968-6979.
36. Murdoch FE, Meier DA, Furlow JD, Grunwald KA, Gorski J,. 1990. Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol. Biochemistry 29: 8377-8385.
37. Ndiaye M, Philippe C, Mukhtar H, Ahmad N,. 2011. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Arch Biochem Biophys 508: 164-170.
38. Nehring JA, Zierold C, DeLuca HF,. 2007. Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci USA 104: 10006-10009.
39. Ornstrup MJ, Harslof T, Kjaer TN, Langdahl BL, Pedersen SB,. 2014. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: A randomized placebo-controlled trial. J Clin Endocrinol Metab 99: 4720-4729.
40. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH,. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421-433.
41. Popov VM, Wang C, Shirley LA, Rosenberg A, Li S, Nevalainen M, Fu M, Pestell RG,. 2007. The functional significance of nuclear receptor acetylation. Steroids 72: 221-230.
42. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA,. 2012. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15: 675-690.
43. Raederstorff D, Kunz I, Schwager J,. 2013. Resveratrol, from experimental data to nutritional evidence: The emergence of a new food ingredient. Ann NY Acad Sci 1290: 136-141.
44. Reis JS, Correa MA, Chung MC, Dos Santos JL,. 2014. Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer. Bioorg Med Chem 22: 2733-2738.
45. Saud SM, Li W, Morris NL, Matter MS, Colburn NH, Kim YS, Young MR,. 2014. Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 35: 2278-2786.
46. Singh CK, Kumar A, LaVoie HA, DiPette DJ, Singh US,. 2012. Resveratrol prevents impairment in activation of retinoic acid receptors and MAP kinases in the embryos of a rodent model of diabetic embryopathy. Reprod Sci 19: 949-961.
47. Stefanska B, Salame P, Bednarek A, Fabianowska-Majewska K,. 2012. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr 107: 781-790.
48. Tennen RI, Michishita-Kioi E, Chua KF,. 2012. Finding a target for resveratrol. Cell 148: 387-389.
49. Uppal H, Saini SP, Moschetta A, Mu Y, Zhou J, Gong H, Zhai Y, Ren S, Michalopoulos GK, Mangelsdorf DJ, Xie W,. 2007. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 45: 422-432.
50. Vanamala J, Reddivari L, Radhakrishnan S, Tarver C,. 2010. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10: 238.
51. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL,. 2014. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 25: 1-18.
52. Wietzke JA, Welsh J,. 2003. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 84: 149-157.
53. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ,. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9: 1033-1045.
54. Yao Y, Li H, Gu Y, Davidson NE, Zhou Q,. 2010. Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling. Carcinogenesis 31: 382-387.